28 105

Cited 0 times in

경구용 steroid나 danazol로 성공적으로 치료된 후천성혈우병 A 2예

Other Titles
 Two Cases of Acquired Hemophilia A Successfully Treated with Oral Steroid or Danazol 
 박선영  ;  김진석  ;  김유리  ;  박인혜  ;  정준원  ;  이승태  ;  한지숙  ;  민유홍 
 Korean Journal of Hematology, Vol.40(1) : 58-63, 2005 
Journal Title
 Korean Journal of Hematology 
Issue Date
Acquired Hemophilia A is a rare and considerably life-threatening coagulopathy, which is caused by the development of autoantibodies against factor VIII (FVIII) in non-hemophilic adults. Acquired FVIII inhibitors can be associated with diverse conditions, such as malignant disorders, medications, autoimmune diseases, postpartum states and others. These autoantibodies inhibit normal coagulation, had results in bleeding complications, which can contribute to mortality in a high percentages of cases. Effective control of the disorder can be achieved by prompt diagnosis and appropriate managements. Generally, the managements of acquired hemophilia A are aimed at treating the acute bleeding and eliminating inhibitors by immunosuppression. Although a range of treatment options exists for patients with acquired hemophilia A, there is no consensus with regard to the optimal therapies for this disorder. Herein, two cases, an 82-year-old man and a 78-year-old man who were successfully treated by steroid or danazol, which is a relatively mild immunosuppressive agent, are reported.
Files in This Item:
T200500976.pdf Download
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
Yonsei Authors
김유리(Kim, Yu Ri) ORCID logo https://orcid.org/0000-0001-5505-0142
김진석(Kim, Jin Seok) ORCID logo https://orcid.org/0000-0001-8986-8436
민유홍(Min, Yoo Hong) ORCID logo https://orcid.org/0000-0001-8542-9583
박선영(Park, Sun Young)
박인혜(Park, In Hae)
이승태(Lee, Seung Tae)
정준원(Cheong, June-Won) ORCID logo https://orcid.org/0000-0002-1744-0921
한지숙(Hahn, Jee Sook)
RIS (EndNote)
XLS (Excel)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.